| mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.37 |
8e-12 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
9e-09 |
| mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-08 |
| mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-08 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-07 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-07 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-07 |
| mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
3e-07 |
| mRNA |
BRD-K90370028 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
9e-07 |
| mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |